首頁 > 市場調查報告書 > 醫療設備

手術用器具

市場調查報告書

商品編碼

1374889

全球腕隧道釋放系統市場 - 2023-2030

Global Carpal Tunnel Release System Market - 2023-2030

出版日期: 2023年11月01日 | 出版商:

DataM Intelligence | 英文 186 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

概述

腕隧道鬆解系統是一種醫療程序和一套用於治療腕隧道症候群（CTS）的技術。 CTS 是一種經常發生的疾病，從前臂延伸到手部的正中神經在穿過手腕中稱為腕管的狹窄通道時受到壓縮或擠壓。

用於治療腕隧道症候群（CTS）的主要手術方法有兩種：開放式腕管鬆解系統和內視鏡腕管鬆解系統。此外，腕隧道症候群的盛行率不斷上升、腕管松解和肌腱病治療的新方法以及市場參與者不斷增加的醫學教育培訓計劃是預計在預測期內推動市場的因素。

動力學

腕隧道鬆解和肌腱病變治療的新方法預計將推動市場成長

腕隧道症候群患者常會出現肌腱疾病，這是一種常見疾病。腕隧道釋放系統最近得到了改進，除了釋放腕管之外還可以解決肌腱病問題。例如，梅奧診所是為數不多的提供超音波引導腕管松解干涉的手部中心之一，這是一種先進的治療方法。超音波導引腕管鬆解術 (TCTR) 是一種較新的微創技術，不需要大切口。與傳統的開放式CTR手術相比，這種方法顯著減少了對周圍組織的損傷，從而減少了術後疼痛并加快了患者的恢復時間。

超音波引導的使用是 TCTR 的一個重要方面。該技術使外科醫生能夠即時查看腕管的內部結構，確保磨料線的準確放置。因此，降低了對周圍結構造成傷害的風險，並且該過程變得更加有效和安全。

此外，TCTR通常在門診進行，患者可以在手術當天回家。這不僅增加了患者的便利性，也減少了醫療費用。 TCTR 是傳統 CTR 的一種侵入性較小的替代方案，這意味著患者的恢復時間可能會更快。這可以使許多人更早恢復日常活動，並且可能需要更少的術後復原。

因此，該手術變得更加廣泛和精細，可能會影響腕管松解術的研究和創新，從而導致技術和工藝的進一步改進。因此，由於上述因素，預計市場在預測期內將繼續成長。

腕隧道釋放系統的高成本預計將阻礙市場成長

腕隧道釋放系統的成本非常高，尤其是 Microaire 81014 等微創釋放系統，約 2,500 美元。這種高昂的成本為病患和醫療機構都帶來了重大問題。由於費用高昂，許多患者不願尋求腕隧道症候群的治療，這可能導致長期疼痛和殘疾。

此外，預算有限地區的醫療機構可能無法負擔這些昂貴的系統，這限制了先進腕管松解技術的使用。因此，與這些系統相關的高成本導致市場滲透率下降，並阻礙其廣泛採用，最終影響受影響地區的患者護理和醫療基礎設施。

Carpal tunnel release system is a medical procedure and a set of techniques that are used to treat carpal tunnel syndrome (CTS). CTS is a frequently occurring condition in which the median nerve, running from the forearm into the hand, gets compressed or squeezed as it passes through a narrow passageway called the carpal tunnel in the wrist.

There are two main surgical approaches used to treat carpal tunnel syndrome (CTS) open carpal tunnel release system and endoscopic carpal tunnel release system. Furthermore, the increasing prevalence of carpal tunnel syndrome, new approaches to carpal tunnel release and treatment of tendinopathy, and rising medical education training programs by the market players are the factors expected to drive the market over the forecast period.

Dynamics

New Approaches to Carpal Tunnel Release and Treatment of Tendinopathy is Expected to Drive Market Growth

Patients with carpal tunnel syndrome often experience tendinopathy, a common condition. Carpal tunnel release systems have recently been improved to address tendinopathy in addition to releasing the carpal tunnel. For instance, the Mayo Clinic is one of the few hand centers that provide ultrasound-guided intervention for carpal tunnel release, which is an advanced treatment. Thread Ultrasound-Guided Carpal Tunnel Release (TCTR) is a newer, minimally invasive technique that does not require large incisions. Compared to traditional open CTR procedures, this approach significantly reduces the damage to the surrounding tissues, resulting in less postoperative pain and faster recovery times for patients.

The use of ultrasound guidance is a crucial aspect of TCTR. This technology enables surgeons to view the internal structures of the carpal tunnel in real time, ensuring accurate and precise placement of the abrasive thread. As a result, the risk of harm to surrounding structures is reduced, and the procedure becomes more effective and safe.

In addition, TCTR is usually done on an outpatient basis, allowing patients to return home on the same day of the operation. This not only increases patient convenience but also results in reduced healthcare expenses. TCTR is a less invasive alternative to traditional CTR, which means that recovery times may be faster for patients. This can enable many individuals to resume their daily activities earlier and potentially require less postoperative rehabilitation.

Therefore, the procedure becomes more widespread and refined, it may influence research and innovation in carpal tunnel release, leading to further improvements in techniques and technologies. Thus, owing to the above factors, the market is expected to drive over the forecast period.

High Cost of Carpal Tunnel Release System is Expected to Hamper the Market Growth

The cost of carpal tunnel release systems, especially minimally invasive ones like the Microaire 81014, is very high around $2,500. This high cost poses a significant problem for both patients and healthcare facilities. Many patients are deterred from seeking treatment for carpal tunnel syndrome due to the high cost, which can lead to prolonged pain and disability.

Additionally, healthcare facilities in regions with limited budgets may not be able to afford these expensive systems, which limits access to advanced carpal tunnel release techniques. Therefore, the high costs associated with these systems have led to reduced market penetration and hindered their widespread adoption, ultimately impacting patient care and healthcare infrastructure in affected regions.

Segment Analysis

The global carpal tunnel release system market is segmented based on product type, surgical approach, technology, end-user and region.

The Endoscopic Carpal Tunnel Release Systems from the Product Type Segment Accounted for Approximately 56.3% of the Carpal Tunnel Release System Market Share

Carpal tunnel syndrome is a common condition where the median nerve in the wrist is compressed and causes discomfort. Endoscopic Carpal Tunnel Release Systems (ECTRS) are minimally invasive surgical tools designed to treat this condition. ECTRS involves the use of a small endoscope, which is a thin tube with a camera, and specialized instruments to release the transverse carpal ligament. This procedure helps to alleviate the pressure on the median nerve and provides relief from the symptoms of carpal tunnel syndrome.

Moreover, it leads to smaller incisions, reduced post-operative pain, faster recovery times, and less scarring when compared to traditional open surgery. ECTRS also enables patients to return to their daily activities and work more quickly, making it a more appealing choice for those searching for a faster and less disruptive remedy for carpal tunnel syndrome.

In addition, ECTRS enables patients to return to their daily activities and work sooner, making it an attractive option for individuals seeking a faster and less disruptive treatment for carpal tunnel syndrome. Furthermore, increasing preference for minimally invasive procedures, increasing the prevalence of carpal tunnel syndrome, and technological advancements are the factors expected to drive the market segment over the forecast period.

For instance, the traditional method for treating this condition involved open surgery, which required a larger incision in the wrist to access and release the compressed median nerve. However, with the advancement of minimally invasive techniques, endoscopic carpal tunnel release has become more popular.

The Endotrac Endoscopic Carpal Tunnel Release System by Stryker is a medical device that enables minimally invasive surgical treatment of carpal tunnel syndrome, a common condition where the median nerve in the wrist is compressed.

Therefore, endoscopic carpal tunnel release systems have gained more popularity among patients and healthcare providers as compared to traditional open surgery in treating carpal tunnel syndrome. This trend reflects the broader shift in medicine toward minimally invasive procedures whenever feasible, as they tend to offer better patient outcomes and experiences. Hence, owing to the above factors, the market segment is expected to hold the largest market share over the forecast period.

Geographical Penetration

North America Accounted for Approximately 39.2% of the Market Share in 2022

North America region is expected to hold the largest market share over the forecast period owing to the increasing prevalence of carpal tunnel syndrome, increasing adoption of surgical intervention, the introduction of new products, and rising healthcare expenditure.

For instance, according to the Mayo Foundation for Medical Education and Research (MFMER) Article, Carpal tunnel syndrome is a common condition that affects many people, and it is estimated that 71% of patients undergo surgical intervention as their primary treatment.

The cost of medical care for carpal tunnel syndrome in the United States is approximately $2 billion per year, and the median time lost from work is just under 30 days. The surgical treatment usually involves an open procedure, while the endoscopic approach is often associated with less postoperative pain and a faster return to work.

Competitive Landscape

The major global players in the carpal tunnel release system market include: Arthrex, Inc., MicroAire Surgical Instruments, LLC, Trice Medical, Smith & Nephew plc, Integra LifeSciences Corporation, Stryker Corporation, Innomed, Inc., A.M. Surgical, Inc., Medical Designs, LLC, and Sonex Health Inc. among others.

COVID-19 Impact Analysis

The COVID-19 pandemic has negatively impacted the carpal tunnel release system market. Due to the COVID-19 pandemic, healthcare facilities have been focusing their resources on treating infected patients while trying to limit the spread of the virus. As a result, many elective surgeries, such as carpal tunnel release procedures, have been postponed or canceled. This temporary delay in surgeries has caused a decline in demand for carpal tunnel release systems.

The pandemic has caused a prominent rise in remote consultations and telemedicine. Therefore, some patients with mild to moderate carpal tunnel syndrome might have chosen non-surgical treatments and remote consultations instead of surgery, which could have impacted the demand for carpal tunnel release systems. The pandemic has also highlighted the significance of safety in healthcare settings. This focus on safety may have accelerated the adoption of minimally invasive techniques such as endoscopic carpal tunnel release systems, which provide advantages such as reduced hospital stays and faster recovery times.

By Product Type

Open Carpal Tunnel Release Systems
Endoscopic Carpal Tunnel Release Systems

By Surgical Approach

Minimally Invasive
Open Surgery

By End User

Hospitals
Ambulatory Surgical Centres
Specialty Clinics
Others

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- U.K.
- France
- Spain
- Italy
- Rest of Europe
South America
- Brazil
- Argentina
- Rest of South America
Asia-Pacific
- China
- India
- Japan
- Australia
- Rest of Asia-Pacific
Middle East and Africa

Key Developments

On August 9, 2022, Sonex Health and The Institute of Advanced Ultrasound Guided Procedures enrolled first patient in the trial of ultrasound guided Carpal Tunnel Release (CTR) versus Traditional Open Release (TUTOR) the first multicenter randomized controlled trial in the United States to compare the efficacy and safety of traditional mini-open carpal tunnel release (mOCTR) and carpal tunnel release using the FDA-cleared UltraGuideCTR and real-time ultrasound guidance.

Why Purchase the Report?

To visualize the global carpal tunnel release system market segmentation based on product type, surgical approach, end user and region as well as understand key commercial assets and players.
Identify commercial opportunities by analyzing trends and co-development.
Excel data sheet with numerous data points of carpal tunnel release system market-level with all segments.
PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
Product mapping available as excel consisting of key products of all the major players.

The global carpal tunnel release system market report would provide approximately 61 tables, 56 figures, and 186 Pages.

Target Audience 2023

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product Type
3.2. Snippet by Surgical Approach
3.3. Snippet by End User
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. New Approaches to Carpal Tunnel Release and Treatment of Tendinopathy
  - 4.1.1.2. Rising Medical Education Training Program by the Market Players
- 4.1.2. Restraints
  - 4.1.2.1. High Cost of Carpal Tunnel Release System
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Pipeline Analysis
5.6. Patent Analysis
5.7. DMI Opinion

6. COVID-19 Analysis

6.1. Analysis of COVID-19
- 6.1.1. Scenario Before COVID
- 6.1.2. Scenario During COVID
- 6.1.3. Scenario Post COVID
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. By Product Type

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 7.1.2. Market Attractiveness Index, By Product Type
7.2. Open Carpal Tunnel Release Systems*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Endoscopic Carpal Tunnel Release Systems

8. By Surgical Approach

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Approach
- 8.1.2. Market Attractiveness Index, By Surgical Approach
8.2. Minimally Invasive*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Open Surgery

9. By End User

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 9.1.2. Market Attractiveness Index, By End User
9.2. Hospitals*
- 9.2.1. Introduction
- 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Ambulatory Surgical Centres
9.4. Specialty Clinics
9.5. Others

10. By Region

10.1. Introduction
- 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 10.1.2. Market Attractiveness Index, By Region
10.2. North America
- 10.2.1. Introduction
- 10.2.2. Key Region-Specific Dynamics
- 10.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Approach
- 10.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.1. Introduction
- 10.3.2. Key Region-Specific Dynamics
- 10.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Approach
- 10.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.3.6.1. Germany
  - 10.3.6.2. UK
  - 10.3.6.3. France
  - 10.3.6.4. Italy
  - 10.3.6.5. Rest of Europe
10.4. South America
- 10.4.1. Introduction
- 10.4.2. Key Region-Specific Dynamics
- 10.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Approach
- 10.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia-Pacific
- 10.5.1. Introduction
- 10.5.2. Key Region-Specific Dynamics
- 10.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Approach
- 10.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
- 10.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia-Pacific
10.6. Middle East and Africa
- 10.6.1. Introduction
- 10.6.2. Key Region-Specific Dynamics
- 10.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
- 10.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Surgical Approach
- 10.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

11. Competitive Landscape

11.1. Competitive Scenario
11.2. Market Positioning/Share Analysis
11.3. Mergers and Acquisitions Analysis

12. Company Profiles

12.1. Arthrex, Inc.*
- 12.1.1. Company Overview
- 12.1.2. Product Portfolio and Description
- 12.1.3. Financial Overview
- 12.1.4. Key Developments
12.2. MicroAire Surgical Instruments, LLC
12.3. Trice Medical
12.4. Smith & Nephew plc
12.5. Integra LifeSciences Corporation
12.6. Stryker Corporation
12.7. Innomed, Inc.
12.8. A.M. Surgical, Inc.
12.9. Medical Designs, LLC
12.10. Sonex Health Inc.

LIST NOT EXHAUSTIVE